Propyretic

Quick links to important sections

Propyretic

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Propyretic

Property Description
Active ingredient Acetaminophen (Paracetamol)
Form Suppository (Rectal)
Pharmacological class Non-opioid analgesic and Antipyretic
Common use Symptomatic relief of fever and pain
Origin Synthetic compound

What Type of Medicine is Propyretic (Acetaminophen)?

Propyretic is a trade name for a medication classified as a non-opioid analgesic and an antipyretic, with the active ingredient being Acetaminophen, globally recognized as Paracetamol. This drug belongs to the para-aminophenol derivative pharmacological class. Propyretic is a synthetic compound designed for the symptomatic relief of pain and fever. Unlike Nonsteroidal Anti-inflammatory Drugs (NSAIDs), its primary therapeutic action is exerted centrally within the central nervous system, a key characteristic that distinguishes its pharmacological profile.

Composition and Pharmaceutical Form: The Rectal Suppository

Propyretic is commonly supplied as a suppository, which is a solid, single-active-ingredient product (monotherapy) formulated for rectal administration. The suppository form consists of the active substance, Acetaminophen, uniformly mixed into an inactive lipid or fatty base (such as hard fat or glycerides). This specialized rectal dosage form is the distinctive feature of Propyretic, making it particularly useful for pediatric patients or any patient who cannot tolerate medicine by mouth. The rectal route offers a crucial alternative for drug delivery when oral administration is complicated, for instance, in cases involving severe nausea or vomiting.

General Purpose: What is the Primary Benefit of this Drug?

The general purpose of Propyretic is to provide effective symptomatic relief from fever (pyrexia) and mild to moderate pain. Its dual function as an analgesic and antipyretic supports its role in essential medical care. The antipyretic effect is primarily achieved by influencing the hypothalamic heat-regulating center to help reset the body's internal thermostat. This focused action provides the primary benefit of alleviating the general discomfort and distress associated with elevated body temperature, serving as a reliable first-line option for general aches and fever management.

What side effects are possible with Propyretic?

Possible Side Effects and Safety Information

The safety profile of Propyretic (Acetaminophen/Paracetamol) is primarily characterized by the risk of hepatotoxicity (severe liver damage), which is dose-dependent and potentially fatal, necessitating strict adherence to regulatory dosage limits. Official government safety information structures the possible adverse reactions into categories based on frequency and affected body systems.


Officially Documented Adverse Reactions

Most clinically significant adverse effects are generally classified as Rare or Very Rare in official regulatory documents. These are categorized into specific system-organ classes:

  • Hepatobiliary Disorders: These include Hepatic Failure and Hepatic Necrosis, which are the most severe, dose-related safety concerns. The risk of liver damage is noted to increase in patients with pre-existing hepatic impairment or those with chronic alcohol consumption.
  • Immune System Disorders: Rare but serious reactions include Anaphylactic Shock and general hypersensitivity reactions.
  • Skin and Subcutaneous Tissue Disorders: Very rare but life-threatening dermatological conditions such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP) are documented.
  • Blood and Lymphatic System Disorders: Rare reports include serious blood disorders like Agranulocytosis and Thrombocytopenia.

Safety Constraints and Considerations

The major safety constraint is the mandatory warning against exceeding the maximum total daily dose, as this action severely increases the risk of irreversible liver damage. Furthermore, long-term use of high doses is associated with the potential for adverse effects on the Renal and Urinary Disorders system. The product is also restricted from use concurrently with any other medication containing Acetaminophen to prevent cumulative toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

A Propyretic (Acetaminophen/Paracetamol) overdose carries the documented risk of severe, life-threatening outcomes, primarily acute liver failure (hepatic necrosis), which can ultimately lead to death. The hepatic system is the principal organ affected, with potential secondary damage to the renal system (acute renal failure) and central nervous system (encephalopathy). Initial overdose manifestations may be non-specific, often including nausea, vomiting, pallor, and general malaise within the first 24 hours. However, these symptoms are unreliable indicators of the eventual severity. Critical signs of injury, such as jaundice and upper quadrant pain, typically do not appear until 48 to 72 hours or later. Patients with risk factors like chronic alcoholism or malnutrition are officially noted as being at an increased susceptibility to toxicity.


Mandated Emergency Response

Government regulatory documents mandate that immediate medical attention must be sought for any known or suspected overdose, even if the patient appears well or symptoms are absent. This urgent action is required because the specific antidote, N-acetylcysteine (NAC), is available, but its efficacy is strongly time-dependent, diminishing significantly if treatment is delayed beyond eight hours post-ingestion. Management involves this immediate intervention and subsequent continuous monitoring of plasma concentration and liver function.

Therapeutic Uses of Propyretic

What Propyretic Treats: Main Uses and Benefits

Propyretic (Acetaminophen/Paracetamol) is commonly used across domains where additional symptomatic support is needed. It is utilized for easing mild to moderate pain and to reduce fever. This supportive role is relevant for managing symptoms associated with acute episodes and compromised oral intake.

The medication helps address symptoms related to heightened physiological activity, specifically the elevated body temperature and generalized distress that accompanies acute conditions like colds, influenza, or other common infections. It also provides supportive relief for mild to moderate somatic pain, which includes symptom clusters that interfere with daily functioning, such as headaches, muscle aches, toothaches, and menstrual discomfort. Propyretic is applied in scenarios where additional management of discomfort is required, especially when patients experience severe nausea or active vomiting; the suppository form may provide supportive relief when oral delivery is not an option.


Quick Fact: Relevant for Mild to Moderate Pain

Propyretic is commonly used to address symptoms related to acute pain, and may be part of symptomatic management for episodic pain relief and fever management when temporary symptomatic assistance is needed.

Regulatory References

  1. NIH MedlinePlus overview on Acetaminophen

Eligibility and Restrictions for Use

Who Can and Cannot Use Propyretic?

This section outlines the population eligibility and exclusion criteria for Propyretic (Acetaminophen/Paracetamol suppository) as defined by official regulatory documentation.

Eligibility Scope

Category Regulatory Statement
Populations Contraindicated Patients with a known hypersensitivity or allergy to the active substance or excipients, or those with severe hepatocellular insufficiency (Child-Pugh ge 9).
Prohibited Use Must not be used concurrently with any other product containing acetaminophen (paracetamol). Specific suppository strengths are contraindicated in children under 6 years of age.
Age-Group Eligibility Approved for use in Adults and Children 12 years and older. Pediatric use is established for children across various age brackets, though infants under one year often require a physician's explicit guidance.
Conditional Use Use requires special caution in patients with impaired renal function, hepatic impairment, chronic alcohol abuse, or conditions causing glutathione depletion (e.g., malnutrition).
Pregnancy/Lactation Status Pregnancy: Permitted for use if clinically needed. Lactation: Generally suitable for use during breastfeeding.

These official statements define eligibility based on organ function, risk of overdose, and allergy status, reflecting non-advisory, label-based regulatory standards.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Propyphenazone's interaction profile, as detailed in regulatory documents, involves both pharmacokinetic and pharmacodynamic mechanisms, leading to specific restrictions and monitoring requirements.

Documented Interactions

Interaction Type Interacting Agent/Category Regulatory Note
Pharmacodynamic Other NSAIDs/Antipyretics Increased risk of cumulative toxicity (e.g., gastrointestinal)
Pharmacodynamic Oral Anticoagulants (e.g., Warfarin) Increased risk of bleeding/hemorrhage; requires close monitoring (e.g., INR)
Pharmacokinetic Lithium, Methotrexate Increased plasma concentration of the co-administered drug due to reduced renal excretion
Non-Medicinal Alcohol Heightened risk of specific organ toxicity (e.g., liver)

Constraints and Requirements

Regulatory information states that co-administration with other non-steroidal anti-inflammatory drugs should be avoided. Due to the interaction with anticoagulants, parameters like the International Normalized Ratio (INR) must be monitored regularly. In patients with renal impairment, the risk of interaction-related toxicity with renally cleared drugs like Lithium and Methotrexate is elevated, requiring careful assessment of the interaction’s clinical significance. Furthermore, taking Propyphenazone with food may delay its absorption, which is a key pharmacokinetic consideration.

Mechanism of Action

Propyretic is a brand name for the compound acetaminophen (paracetamol). Its primary action involves the central nervous system (CNS). The drug functions as an inhibitor of cyclooxygenase (COX) activity, predominantly within the CNS, where peroxide tone is low. This interaction reduces the availability of the ferryl protoporphyrin IX radical cation at the peroxidase (POX) site of the COX enzyme, thereby limiting the conversion of arachidonic acid into prostaglandin (PG) precursors, such as PGG2 and PGH2. The intracellular consequence is a diminished synthesis of prostaglandins, notably prostaglandin E2 ( PGE2), within the hypothalamus. Reduced PGE2 concentration within the thermoregulatory center of the hypothalamus leads to a downstream cascade that modifies the set point for body temperature. This system-level physiological modulation results in increased peripheral heat dissipation, adjusting core body temperature toward a lower setting.

Furthermore, an active metabolite, AM404 (formed by the conjugation of p-aminophenol and arachidonic acid via fatty acid amide hydrolase), may also contribute to the drug's mechanism. AM404 acts as an agonist at central transient receptor potential vanilloid subtype-1 (TRPV1) receptors and inhibits the uptake of endocannabinoids, modulating descending serotonergic pathways and synaptic transmission within the spinal cord.

Dosage and Administration Information

The administration of Propyretic (Acetaminophen/Paracetamol) involves specific parameters focused on the rectal route and precise dosing. The use of this suppository form is primarily intended for patients who are unable to take oral medication, such as those experiencing nausea or vomiting.

Official Administration Guidelines

Route and Frequency The medication must be used rectally only. The standard dosing regimen for adults and children 12 years and older is typically between 325 mg and 1000 mg per administration. This dose may be repeated every 4 to 6 hours as needed for temporary symptomatic relief. A minimum interval of 4 hours is required between administrations.

Dose Limits and Duration Crucially, the total quantity of acetaminophen administered from all sources must not exceed 4000 mg (4 g) in any 24-hour period. Dosing for children is based on the child's weight and age, often guided by a 10 mg/kg to 15 mg/kg rule for a single dose. The overall course of self-administration is intended for short-term duration, generally not exceeding three days for fever or five days for pain relief without medical consultation.

Procedural Rules Administration involves removing the wrapper and carefully inserting the suppository well into the rectum. Only whole suppositories should be used, and they must not be broken before administration. Propyretic must not be administered concurrently with any other product containing acetaminophen.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Propyretic


Evidence for Symptomatic Relief of Fever (Antipyresis)

Research exploring how symptoms change over time has focused on Propyretic suppositories' role within the study of fever (pyrexia). Studies primarily use Randomized Controlled Trials (RCTs) and aggregated Meta-analyses to examine outcomes related to body temperature measurements. These studies were mostly applied in research contexts involving febrile pediatric patients (children, toddlers, and infants). Researchers monitored outcomes related to physiological strain or stress, specifically measuring the change in body temperature and the time required to observe those changes.

Studies report how temperatures evolved in the observed populations, noting that trials tracked changes in temperature over short-term periods. Findings describe patterns observed in studies where temperature measurements were compared against placebo or other administration routes. However, the absorption of the active ingredient via the rectal suppository form was often prolonged or erratic. Evidence quality varies across studies, and some meta-analyses noted mixed findings or inconsistent results when comparing the suppository to the oral form, leading to some uncertainty regarding the measured outcomes of the rectal route for the short-term use.


Evidence for Mild to Moderate Pain Relief (Analgesia)

Propyretic was evaluated in studies focusing on outcomes related to physical discomfort, often in research exploring short-term symptom changes associated with mild to moderate pain. Research has explored the suppository form's inclusion in acute pain management strategies, particularly in contexts like postoperative care. Researchers primarily examined patient-reported outcomes describing perceived discomfort (such as standardized pain scores) and monitored the amount of other pain medication required by patients during the study period.

Research highlights changes measured during the study period, showing patterns where the required amount of supplemental opioid analgesics was recorded as an outcome for patients who received the suppository alongside other agents. The known variability in absorption from the rectal route means that the time needed to achieve target levels for the active ingredient is not uniform. Comparative evidence against other routes for general pain relief is lacking, and long-term effects are not fully established.

Key Studies & References Clinical Pharmacokinetics of Paracetamol (Acetaminophen) in Children

Frequently Asked Questions (FAQ)

Common questions about Propyretic (FAQ)


Q: What is the main difference between Propyretic and over-the-counter pain relievers?

A: Propyretic is a brand name for the active ingredient acetaminophen (paracetamol), which is classified as a non-opioid analgesic and antipyretic. Unlike Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as ibuprofen, official information describes acetaminophen as acting primarily in the central nervous system to relieve pain and fever, rather than reducing inflammation throughout the body. Additionally, this specific product is a suppository for rectal use, which differs from most common oral pain relievers.

Q: Does Propyretic contain aspirin or ibuprofen?

A: No. The active ingredient in Propyretic is acetaminophen, also known as paracetamol. According to its pharmacological classification, it is not an NSAID like aspirin or ibuprofen.

Q: Can Propyretic be used for general back pain relief?

A: Propyretic is indicated for the temporary symptomatic relief of mild to moderate pain, according to regulatory documents. General types of pain, such as back pain, may fall under this classification. Official documentation focuses on the intensity of the pain (mild to moderate), rather than the specific location.

Q: Can Propyretic make you feel dizzy or drowsy?

A: Dizziness or drowsiness are generally not listed as common side effects for acetaminophen suppositories in official product information. Regulatory warnings mention that serious adverse effects or overdose have been associated with severe dizziness or other central nervous system symptoms.

Q: Is it common to have an upset stomach when taking Propyretic?

A: Upset stomach is not commonly reported as a primary side effect of this medication. Official regulatory warnings primarily focus on the severe risk of liver damage and rare serious skin reactions. Official regulatory warnings note that nausea, vomiting, or stomach pain are recognized symptoms associated with an acetaminophen overdose.

Q: What are the signs of a serious allergic reaction to Propyretic?

A: Official information documents rare but serious reactions such as anaphylactic shock and life-threatening skin conditions (like Stevens-Johnson Syndrome). Signs may include severe rash, hives, difficulty breathing, or swelling of the face and throat. These severe reactions, as noted in regulatory materials, represent medical emergencies.

Q: Does Propyretic have any known interactions with common vitamins or supplements?

A: Specific interactions with common vitamins are not typically highlighted on regulatory labels. Official guidance indicates that patients should inform their healthcare professional of all drugs, vitamins, and supplements being taken, allowing them to assess potential interactions.

Q: Can I take Propyretic if I am already taking blood pressure medication?

A: Regulatory warnings stress the need to consult with a healthcare professional before taking Propyretic while on any other medication, including those used for blood pressure. The potential for interactions between the active ingredients is a matter for a doctor or pharmacist to assess.

Q: Is Propyretic safe for use by older adults?

A: Regulatory documents indicate that geriatric-specific issues have not been demonstrated to strictly limit the usefulness of the active ingredient in the elderly. However, special caution is advised in patients with impaired kidney or liver function, conditions which may be more prevalent in the older adult population.

Q: Are there any specific foods or drinks to avoid when taking Propyretic?

A: Official product information notes that alcohol is linked to a heightened risk of liver toxicity and its concurrent use is cautioned against. While food may delay the absorption of the active ingredient, no other specific non-alcoholic foods or drinks are commonly listed as requiring strict avoidance.

Q: Is Propyretic considered a narcotic or a controlled substance?

A: Propyretic contains acetaminophen, which is classified as a non-opioid analgesic, meaning it is not a narcotic. Regulatory classifications confirm it does not carry the same risk of dependence as opioid pain relievers. The specific status as a controlled substance varies by country and is related to scheduling decisions.

Q: How do doctors generally monitor patients taking Propyretic long-term?

A: Official documentation implies monitoring is necessary, particularly as long-term use of high doses is associated with potential adverse effects on the kidney and liver. For instance, close monitoring of blood parameters, such as the International Normalized Ratio (INR), is required if the drug is taken alongside certain blood thinners.

Q: Is Propyretic available in different strengths or forms?

A: The Propyretic product described in official materials is formulated as a rectal suppository. This form is commonly available in different dosages to accommodate varied patient needs, particularly in pediatric care.

Q: What is the latest research saying about the long-term use of Propyretic?

A: Official research overviews indicate that long-term effects of the suppository form are not fully established. Regulatory documents indicate the product is for short-term use and warn that long-term use of high doses is associated with potential adverse effects on the renal and urinary systems.

Q: Does Propyretic affect birth control or hormone levels?

A: Some drug interaction studies suggest that oral contraceptives may decrease or delay the effects of acetaminophen. However, the regulatory consensus is that concurrent administration at usual therapeutic dosages is unlikely to result in significant additional risk. Consultation with a healthcare professional is noted as necessary for assessing risk.

Q: What if I take Propyretic and it doesn't seem to work for me?

A: Official labeling contains instructions to discontinue use and consult a doctor if pain worsens or lasts more than five days, or if fever lasts more than three days. Continuing symptoms may indicate a more serious condition that requires medical assessment.

Q: Are there any official warnings about operating machinery while using Propyretic?

A: While there is no standard warning for non-opioid acetaminophen regarding driving, regulatory guidance advises patients to understand how any medication affects them before operating machinery. This is particularly relevant if rare side effects, such as dizziness from overdose or hypersensitivity, should occur.

Q: What does the term 'non-narcotic analgesic' mean in the context of Propyretic?

A: This term indicates that the drug relieves pain (analgesic) without being a narcotic (opioid) and therefore does not carry the same risk of dependence or addiction. Propyretic's active ingredient, acetaminophen, is officially classified this way.

Q: How long after stopping Propyretic will it be cleared from my system?

A: Official labeling does not provide specific clearance times, as this information can be complex and depends on individual health factors. Clearance time is often discussed in terms of half-life (the time it takes for half of the drug to leave the system), which is generally short for acetaminophen.

Q: Does Propyretic interact with herbal teas or supplements?

A: Regulatory guidance indicates the importance of consulting a healthcare professional about all supplements, including herbal teas. They need to assess any potential interaction risks before use, as combination safety is not addressed in standard product warnings.

Q: Does Propyretic carry a Black Box Warning from the FDA?

A: Prescription products containing acetaminophen are required by the FDA to have a Boxed Warning (often called a 'Black Box Warning'). This is the strongest safety measure, used to highlight the potential for severe, life-threatening liver injury associated with the drug.

Q: Does Propyretic interact with mood stabilizers or antidepressants?

A: Official guidance stresses that patients must inform their doctor or pharmacist of all medications, including those used for mental health conditions. The assessment of interaction risk and any required dose adjustments are matters for a healthcare professional.

Q: Why do official materials recommend discontinuing Propyretic before some surgeries?

A: A doctor may advise discontinuation because acetaminophen can interact with blood thinners like Warfarin, increasing the risk of bleeding. This caution is generally observed as part of a standard pre-surgical protocol to minimize complication risks, even though Propyretic is not an NSAID.

Q: Can Propyretic cause constipation or diarrhea?

A: Constipation is not commonly listed in the official adverse reactions for this product. Diarrhea, however, is a potential symptom that has been associated with acetaminophen overdose, according to some regulatory warnings.

Q: What are the most commonly reported side effects of Propyretic in clinical trials?

A: Official documents focus on listing the rare or very rare serious side effects, such as liver failure or severe skin reactions. While non-serious side effects are recorded in clinical trials, regulatory summaries typically only emphasize the most clinically significant safety concerns.

How should Propyretic be stored and disposed of?

The storage and disposal of Propyretic (Acetaminophen suppositories) must strictly follow the official instructions documented in government labeling to maintain product quality and ensure safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze.
Protection Keep away from moisture, excess heat, and direct light.
Container Must be kept in the original container and be tightly closed. Do not use if the individual wrapper is damaged.
Child Safety Keep out of the sight and reach of children at all times.

Disposal Instructions

Unused or expired suppositories must be discarded properly. The preferred method is to use a medicine take-back program. The product must not be flushed down the toilet or disposed of in wastewater. If a take-back program is unavailable, follow regulatory instructions for household disposal by mixing the medicine with an undesirable substance before placing it in a sealed container for trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Propyretic found in:

A-Z Index: